Please check your internet connection and try again.
# Dexamethasone in Chronic ITP
## Overview
Dexamethasone is a potent synthetic corticosteroid with potent anti-inflammatory and immunosuppressive effects. It is used in the management of chronic immune thrombocytopenia (ITP) primarily as a second-line agent or in specific protocols for induction of remission.
## Primary Indications
* Treatment of chronic immune thrombocytopenia (ITP) in adults and children, often in combination with other agents or as part of specific treatment protocols.
## Adult Dosing
* **Common Protocol (e.g., "high-dose dexamethasone pulse"):** 40 mg orally or intravenously once daily for 4 consecutive days. This regimen may be repeated monthly if a response is achieved and tolerated.
* **Alternative Regimens:** Dosing can vary significantly based on specific national or institutional guidelines and the patient's response and tolerance. Some protocols may use lower daily doses for more prolonged periods or as part of complex regimens.
## Pediatric Dosing
* Dosing in pediatric patients with chronic ITP is highly individualized and often guided by institutional protocols.
* A common approach involves high-dose dexamethasone pulses similar to adults, but specific mg/kg doses and maximums should be confirmed with pediatric hematology guidelines. For example, doses of 0.6 mg/kg/day (maximum 40 mg/day) orally or IV for 4 days have been utilized.
## Dose Adjustments
* No specific dose adjustments are routinely recommended for renal or hepatic impairment based on current guidelines, but caution and close monitoring are advised.
## Contraindications
* Systemic fungal infections.
* Known hypersensitivity to dexamethasone or other corticosteroids.
* Use with extreme caution in patients with active infections, especially tuberculosis, and in those with a history of latent tuberculosis.
## Adverse Effects
* **Common:** Hyperglycemia, insomnia, mood changes (anxiety, euphoria, psychosis), increased appetite, weight gain, fluid retention, gastrointestinal upset, acne.
* **Serious:** Adrenal suppression, Cushingoid appearance, osteoporosis, peptic ulcer disease, increased susceptibility to infection, cardiovascular events (hypertension, arrhythmias), cataracts, glaucoma, myopathy, psychiatric disturbances.
## Key Drug Interactions
* **CYP3A4 Inducers (e.g., rifampin, phenytoin, carbamazepine):** May decrease dexamethasone levels and efficacy.
* **CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir):** May increase dexamethasone levels.
* **Potassium-Depleting Agents (e.g., diuretics, amphotericin B):** Increased risk of hypokalemia.
* **Live Vaccines:** Dexamethasone can impair the immune response and increase the risk of disseminated infection from live vaccines. Avoid concurrent use.
## Monitoring
* **Blood Glucose:** Especially in patients with diabetes or at risk.
* **Electrolytes:** Particularly potassium.
* **Signs of Infection:** Monitor for fever, new or worsening infections.
* **Blood Pressure:** Monitor for hypertension.
* **Bone Mineral Density:** With
